今开:0.0 | 昨收:0.057 |
最高:0.0 | 最低:0.0 |
涨停价:0.0 | 跌停价:0.0 |
总市值:5152671.0 |
矫首遐观2021-06-03 06:35
$Sqz Biotechnologies(SQZ)$ SQZ利用其特有的细胞挤压技术成立了三个药物发现平台,a平台是利用工程B细胞疗法开发针对癌症、传染病疫苗。去年十月工程B细胞疗法企业BE BIO完成了5200万A轮融资,号称是业内第一家。而实际上SQZ在18年就跟罗氏扩展了工程B细胞药物开发的合作协议,罗氏至今己支付了1...查看全文
$Rubius Therapeutics(RUBY)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-23-030329 Act: 34 Size: 2 MB 网页链接
$Rubius Therapeutics(RUBY)$ 8-K Current report, items 3.01 and 5.02 Accession Number: 0001104659-23-028428 Act: 34 Size: 204 KB 网页链接
$Rubius Therapeutics(RUBY)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001088875-23-000072 Act: 34 Size: 10 KB 网页链接
$Rubius Therapeutics(RUBY)$ PRER14A Preliminary Proxy Soliciting materials Accession Number: 0001104659-23-027696 Act: 34 Size: 2 MB 网页链接
$Rubius Therapeutics(RUBY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-026139 Size: 5 KB 网页链接
$Rubius Therapeutics(RUBY)$ PRE 14A Other preliminary proxy statements Accession Number: 0001104659-23-025672 Act: 34 Size: 508 KB 网页链接
$Rubius Therapeutics(RUBY)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001709401-23-000005 Act: 34 Size: 7 MB 网页链接
$Rubius Therapeutics(RUBY)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-025604 Act: 33 Size: 28 KB 网页链接
$Rubius Therapeutics(RUBY)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-025605 Act: 33 Size: 28 KB 网页链接
$Rubius Therapeutics(RUBY)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-025606 Act: 33 Size: 28 KB 网页链接